It has been shown that if Cxxc5 produces a heterozygous variant, it leads to decreased levels of antibody production in the body, progressive loss of B cells, and recurrent lung and gastrointestinal infections; moreover, Cxxc5 does not play a role in early B cell production but may affect their proliferation and survival (70). This evidence concerns the gene CXXC5 and digestive system infectious disorder.